hotspot -WSS

hotspot

author：Wikipedia 2025-09-06 03:28:05 - browse：4378

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： What drug price negotiations mean for Medicare Part D

knowledge

Wikipedia

WSS

The a glaring gap in research on serious mental illness and primary care

How to fix cancer clinical trials' diversity problem

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

H.R. 3 is the wrong path to lower drug costs

Alnylam reports growth in sales of rare disease treatments

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

explore

hotspot

explore

Guidelines to prevent youth baseball injuries need more muscle

H.R. 3 is the wrong path to lower drug costs

How one medical school became remarkably diverse

What American doctors can learn from their Israeli counterparts

At least 13 dead in Texas as scorching temps continue

A new House health package & hospitals’ new site

Virginia high school admissions case could be legal follow

The a glaring gap in research on serious mental illness and primary care

Duchenne breakthrough therapy leaves behind pioneering families

Late stage cancers on the rise after pandemic delayed screenings

Wikipedia

How to fix cancer clinical trials' diversity problem

The cancer stories no one wants to hear

The 10 drugs up first for Medicare price negotiation

How generative AI is inspiring dreams of a health data revolution

Covid hospitalizations on the rise, Humana says

Crinetics acromegaly drug succeeds in late

knowledge

knowledge

Wikipedia

knowledge